Company news

Summit Therapeutics Inc. news in 2022

Summit Therapeutics Inc.'s news releases, calls and decks from 2022, newest first.

View company

Summit Therapeutics Partners with Akeso Inc. in Deal for Up to $5 Billion to In-License Breakthrough Innovative Bispecific Antibody

December 5, 2022

Summit Therapeutics Appoints Experienced Clinical Leader Dr. Alessandra Cesano to its Board of Directors

November 16, 2022

Summit Therapeutics Inc. Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended September 30, 2022

November 8, 2022

Summit Therapeutics Presents Ri-CoDIFy Trial Results for Microbiome-Sparing Ridinilazole at IDWeek 2022

October 19, 2022

Summit Therapeutics to Present Ri-CoDIFy Trial Results for Microbiome-Sparing Ridinilazole at IDWeek 2022

October 12, 2022

Summit Therapeutics Appoints Dr. Robert Booth, Renowned Executive and Scientific Leader, to its Board of Directors

October 2, 2022

Summit Therapeutics Inc Reports Financial Results and Operational Progress for the Second Quarter Ended June 30, 2022

August 10, 2022

Summit Therapeutics Closes Fully-Subscribed $100 Million Rights Offering

August 8, 2022

Summit Therapeutics Appoints Dr. Maky Zanganeh as Co-CEO & President

July 25, 2022

Summit Therapeutics Announces Commencement of $100 Million Rights Offering

July 17, 2022

Summit Therapeutics Provides Update on Ridinilazole

July 13, 2022

Summit Therapeutics Announces $100 Million Rights Offering

June 21, 2022

Summit Therapeutics’ Upcoming Annual Shareholders’ Meeting

June 2, 2022

Summit Therapeutics Appoints Ankur Dhingra as Chief Financial Officer

May 31, 2022

Summit Therapeutics Inc Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2022

May 10, 2022

Summit Therapeutics Inc Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 2021

March 16, 2022

Summit Therapeutics Announces Postponement of Its Planned Rights Offering

February 8, 2022

Summit Therapeutics Announces Rights Offering

January 24, 2022

Summit Therapeutics Today Presents Its Company Vision at 40th Annual J.P. Morgan Healthcare Virtual Conference

January 9, 2022

Summit Therapeutics to Present Company Vision at 40th Annual J.P. Morgan Healthcare Virtual Conference

January 4, 2022

Decks in 2022